Dr Michal SieniawskiClinical Research Associate
Email: m.k.sienawski@ncl.ac.uk Telephone: +44 (0) 191 222 8879 Address: Northern Institute for Cancer Research
Culpin R, Sieniawski M, Anderson J, Angus B, Proctor S, Menon G, McCabe K, Milne P, Crosier S, Mainou-Fowler T. Mature microRNAs of the miR-17-92 cluster predict for disease outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with CHOP-R immunochemotherapy .
In: International Journal of Molecular Medicine . 2011, Spandidos Publications.
Halbsguth T, Nogová L, Mueller H, Sieniawski M, Eichenauer D, Schober T, Nisters-Backes H, Borchmann P, Diehl V, Engert A, Josting A. Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: A report from the German Hodgkin Study Group (GHSG) .
Blood 2010, 116 (12), 2026-2032.
